Mutations in KMT2C, BCOR and KDM5C Predict Response to Immune Checkpoint Blockade Therapy in Non-Small Cell Lung Cancer

SIMPLE SUMMARY: Efficient biomarkers are urgently needed to predict response to immune checkpoint blockade (ICB) therapy for non-small cell lung cancer (NSCLC), particularly NSCLC with low tumor mutational burden (TMB). Here, we show that mutations of three chromatin remodeling-related genes, includ...

Descripción completa

Detalles Bibliográficos
Autores principales: Liu, Dingxie, Benzaquen, Jonathan, Morris, Luc G. T., Ilié, Marius, Hofman, Paul
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2022
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9179442/
https://www.ncbi.nlm.nih.gov/pubmed/35681795
http://dx.doi.org/10.3390/cancers14112816

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9179442/
https://www.ncbi.nlm.nih.gov/pubmed/35681795
http://dx.doi.org/10.3390/cancers14112816

Ejemplares similares